FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

783439006: Ravulizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3758942014 Ravulizumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3758943016 Ravulizumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ravulizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Ravulizumab Is a Substance with complement 5 inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Ravulizumab Has disposition Complement 5 inhibitor true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing ravulizumab (medicinal product) Has active ingredient True Ravulizumab Inferred relationship Existential restriction modifier 1
Ravulizumab Has active ingredient True Ravulizumab Inferred relationship Existential restriction modifier 1
Product containing ravulizumab in parenteral dose form (medicinal product form) Has active ingredient True Ravulizumab Inferred relationship Existential restriction modifier 1
Product containing only ravulizumab in parenteral dose form (medicinal product form) Has active ingredient True Ravulizumab Inferred relationship Existential restriction modifier 1
Ravulizumab 300mg/3ml solution for infusion vials Has specific active ingredient True Ravulizumab Inferred relationship Existential restriction modifier
Ravulizumab 1.1g/11ml solution for infusion vials Has specific active ingredient True Ravulizumab Inferred relationship Existential restriction modifier
Ultomiris 300mg/3ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) Has specific active ingredient True Ravulizumab Inferred relationship Existential restriction modifier
Ravulizumab 300mg/3ml solution for infusion vials 1 vial Has specific active ingredient True Ravulizumab Inferred relationship Existential restriction modifier
Ultomiris 1,100mg/11ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) Has specific active ingredient True Ravulizumab Inferred relationship Existential restriction modifier
Ultomiris 1,100mg/11ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial Has specific active ingredient True Ravulizumab Inferred relationship Existential restriction modifier
Ultomiris 300mg/3ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial Has specific active ingredient True Ravulizumab Inferred relationship Existential restriction modifier
Ravulizumab 1.1g/11ml solution for infusion vials 1 vial Has specific active ingredient True Ravulizumab Inferred relationship Existential restriction modifier
Ultomiris 300mg/30ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) 1 vial Has specific active ingredient True Ravulizumab Inferred relationship Existential restriction modifier
Ravulizumab 300mg/30ml solution for infusion vials Has specific active ingredient True Ravulizumab Inferred relationship Existential restriction modifier
Ravulizumab 300mg/30ml solution for infusion vials 1 vial Has specific active ingredient True Ravulizumab Inferred relationship Existential restriction modifier
Ultomiris 300mg/30ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) Has specific active ingredient True Ravulizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start